Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Gaia
GAIA
$48.4M
| $211K | ﹤0.01% |
54,763
| – | – |
|
3252
iShares 10-20 Year Treasury Bond ETF
TLH
$10.9B
| $207K | ﹤0.01% |
1,991
-223
| -10% | -$22.6K |
|
3253
Invesco California AMT-Free Municipal Bond ETF
PWZ
$1.16B
| $206K | ﹤0.01% |
8,656
-180
| -2% | -$4.4K |
|
3254
QuickLogic
QUIK
$248M
| $205K | ﹤0.01% |
40,187
| – | – |
|
|
QIPT
3255
DELISTED
Quipt Home Medical
QIPT
| $205K | ﹤0.01% |
87,829
-12,174
| -12% | -$33.4K |
|
3256
Energy Transfer Partners
ET
$69.8B
| $204K | ﹤0.01% |
+10,965
| New | +$214K |
|
3257
NLI Holdings
NL
$283M
| $203K | ﹤0.01% |
25,715
| – | – |
|
|
DDI
3258
DoubleDown Interactive
DDI
$592M
| $202K | ﹤0.01% |
+20,394
| New | +$207K |
|
3259
1stdibs.com
DIBS
$173M
| $202K | ﹤0.01% |
66,302
-4,024
| -6% | -$14.4K |
|
3260
Destination XL Group
DXLG
$31.5M
| $201K | ﹤0.01% |
137,389
-15,360
| -10% | -$35.9K |
|
|
LNAI
3261
Lunai Bioworks
LNAI
$11.6M
| $197K | ﹤0.01% |
4,527
| – | – |
|
3262
Lexeo Therapeutics
LXEO
$344M
| $195K | ﹤0.01% |
56,174
-7,700
| -12% | -$34.1K |
|
3263
Waldencast
WALD
$191M
| $195K | ﹤0.01% |
64,895
| – | – |
|
3264
Paysign
PAYS
$512M
| $194K | ﹤0.01% |
91,615
| – | – |
|
3265
HireQuest
HQI
$182M
| $193K | ﹤0.01% |
16,229
| – | – |
|
|
GOCO
3266
DELISTED
GoHealth
GOCO
| $189K | ﹤0.01% |
15,371
| – | – |
|
3267
The ONE Group
STKS
$55.9M
| $186K | ﹤0.01% |
62,260
| – | – |
|
3268
Rekor Systems
REKR
$90.1M
| $185K | ﹤0.01% |
208,087
+18,639
| +10% | +$29.4K |
|
|
RAPT
3269
DELISTED
RAPT Therapeutics
RAPT
| $184K | ﹤0.01% |
18,868
+9,996
| +113% | +$98.3K |
|
3270
Veru
VERU
$36.9M
| $184K | ﹤0.01% |
37,529
+6,504
| +21% | +$40.3K |
|
3271
Greenwich LifeSciences
GLSI
$211M
| $181K | ﹤0.01% |
19,007
+2,552
| +16% | +$30.9K |
|
|
GOOS
3272
Canada Goose Holdings
GOOS
$867M
| $180K | ﹤0.01% |
22,693
+8,690
| +62% | +$85.7K |
|
3273
Taboola.com
TBLA
$1.06B
| $180K | ﹤0.01% |
60,898
-176,586
| -74% | -$604K |
|
3274
Red Cat Holdings
RCAT
$1.32B
| $177K | ﹤0.01% |
30,065
+6
| +0% | +$48 |
|
3275
Lifetime Brands
LCUT
$195M
| $173K | ﹤0.01% |
35,087
| – | – |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.